MedDay is a biotechnology company developing new drugs targeting brain metabolism to treat diseases of the nervous system. Learn more about MedDay's story.
MedDay currently has molecules in development for treatment of multiple sclerosis, autism and Alzheimer’s disease.
MedDay addresses areas of unmet need in neurological and psychiatric diseases through the brain metabolism. This approach relies on unique clinical and pharmaceutical development expertise in the field of rare inborn errors of metabolism.